Actavis is introducing new drug packaging for its injectable products in the UK, incorporating best practice in the pharmaceutical sector.Vialshield packaging is designed to reduce the chance of breakage and spillage and help protect people working with cytotoxics. Jonathan Wilson, director of hospital and brands at Actavis, says: “The addition of Vialshield will help protect pharmacy staff and minimise potential exposure to cytotoxics.”

The new packaging is now available for gemcitabine and will be introduced on all other oncology products available from Actavis.Vialshield has already been launched in Ireland and a number of other EU countries.Actavis UKTel: 0800 373573